Generate Chart For |
|
|
(Chart displayed below) |
Rat Strains
{{sample.term}}
|
Measurement Methods
{{method.term}}
|
|
|
10 | plasma insulin level | F344/NHsd | female | 17 | mU/l | fasting (for 16 hours) then glucose solution (2 g/kg) | 11615 | fasting (for 16 hours) | glucose solution (2 g/kg) | | |
10 | plasma insulin level | WKY/NHsd | female | 20 | mU/l | fasting (for 16 hours) then glucose solution (2 g/kg) | 11614 | fasting (for 16 hours) | glucose solution (2 g/kg) | | |
10 | plasma insulin level | F344/NHsd | male | 43 | mU/l | fasting (for 16 hours) then glucose solution (2 g/kg) | 11613 | fasting (for 16 hours) | glucose solution (2 g/kg) | | |
10 | plasma insulin level | WKY/NHsd | male | 64.1 | mU/l | fasting (for 16 hours) then glucose solution (2 g/kg) | 11612 | fasting (for 16 hours) | glucose solution (2 g/kg) | | |
N/A | plasma insulin level | Crl:SD | male | 53 | mU/l | controlled fructose content diet (66 %) (between 14 and 28 days) | 75879 | controlled fructose content diet (66 %) (between 14 and 28 days) | | | |
8 | plasma insulin level | Crl:SD | male | 68 | mU/l | controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days) | 75880 | controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) | controlled fructose content diet (66 %) (between 14 and 28 days) | insulin (2 U/kg/d) (for 14 days) | |
9 | plasma insulin level | Crl:SD | male | 51 | mU/l | controlled fructose content diet (66 %) (between 14 and 28 days) | 75847 | controlled fructose content diet (66 %) (between 14 and 28 days) | | | |
8 | plasma insulin level | Crl:SD | male | 33 | mU/l | control condition | 75848 | control condition | | | |
10 | plasma insulin level | Crl:SD | male | 32 | mU/l | controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) | 75849 | controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) | controlled fructose content diet (66 %) (between 14 and 28 days) | | |
8 | plasma insulin level | Crl:SD | male | 26 | mU/l | controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) | 75850 | controlled metformin content drinking water (350-500 mg/kg/d) (between 21 and 35 days) | | | |
4 | plasma insulin level | Crl:WI | male | 14.5 | mU/l | control condition | 103089 | control condition | | | |
4 | plasma insulin level | GK/CskCrljCrl | male | 12.32 | mU/l | control condition | 103090 | control condition | | | |
12 | plasma insulin level | SS | male | 4 | mU/l | controlled sodium content diet (0.3 %) (for 42 days) | 103326 | controlled sodium content diet (0.3 %) (for 42 days) | | | |
13 | plasma insulin level | SR | male | 4 | mU/l | controlled sodium content diet (0.3 %) (for 42 days) | 103327 | controlled sodium content diet (0.3 %) (for 42 days) | | | |
13 | plasma insulin level | SS | male | 5 | mU/l | controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) | 103328 | controlled sodium content diet (0.3 %) (for 42 days) | controlled sodium content diet (8 %) (for 42 days) | | |
11 | plasma insulin level | SR | male | 5 | mU/l | controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) | 103329 | controlled sodium content diet (0.3 %) (for 42 days) | controlled sodium content diet (8 %) (for 42 days) | | |
12 | plasma insulin level | SS | male | 6 | mU/l | controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) | 103330 | controlled sodium content diet (0.3 %) (for 42 days) | controlled sodium content diet (8 %) (for 84 days) | | |
13 | plasma insulin level | SR | male | 5 | mU/l | controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) | 103331 | controlled sodium content diet (0.3 %) (for 42 days) | controlled sodium content diet (8 %) (for 84 days) | | |
6 | plasma insulin level | GK | male | 101 | mU/l | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) | 110616 | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) | | | |
6 | plasma insulin level | GK | female | 42 | mU/l | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) | 110618 | controlled dehydroepiandrosterone content diet (0.2 %) (for 28 days) | | | |
10 | plasma insulin level | BN/NHsdMcwi | male | 20.37 | mU/l | controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) | 102092 | controlled sodium chloride content drinking water (1 %) (for 7 days) | controlled sodium chloride content drinking water (2 %) (for 7 days) | controlled sodium chloride content drinking water (1 %) (for 9 days) | water (for 12 days) |
10 | plasma insulin level | LH/Mav | male | 29.17 | mU/l | controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) | 102093 | controlled sodium chloride content drinking water (1 %) (for 7 days) | controlled sodium chloride content drinking water (2 %) (for 7 days) | controlled sodium chloride content drinking water (1 %) (for 9 days) | water (for 12 days) |
10 | plasma insulin level | LH-Chr 13BN/Mav | male | 30.84 | mU/l | controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) | 102094 | controlled sodium chloride content drinking water (1 %) (for 7 days) | controlled sodium chloride content drinking water (2 %) (for 7 days) | controlled sodium chloride content drinking water (1 %) (for 9 days) | water (for 12 days) |
9 | plasma insulin level | BN-Chr 13LH/MavRrrc | male | 23.41 | mU/l | controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) | 102095 | controlled sodium chloride content drinking water (1 %) (for 7 days) | controlled sodium chloride content drinking water (2 %) (for 7 days) | controlled sodium chloride content drinking water (1 %) (for 9 days) | water (for 12 days) |
10 | plasma insulin level | HTG | not specified | 13 | mU/l | fasting (for 16 hours) | 68984 | fasting (for 16 hours) | | | |
10 | plasma insulin level | BN/OrlIcoCrlf | not specified | 14.04 | mU/l | fasting (for 16 hours) | 68985 | fasting (for 16 hours) | | | |
10 | plasma insulin level | COP/OlaHsd | not specified | 29.12 | mU/l | fasting (for 16 hours) | 68572 | fasting (for 16 hours) | | | |
10 | plasma insulin level | COP.DA-(D16Rat12-D16Rat90)/Mco | not specified | 32.5 | mU/l | fasting (for 16 hours) | 68573 | fasting (for 16 hours) | | | |
10 | plasma insulin level | COP.DA-(D3Rat233-D3Mgh14)/Mco | not specified | 26.52 | mU/l | fasting (for 16 hours) | 68574 | fasting (for 16 hours) | | | |
6 | plasma insulin level | GK/MolTac | male | 37.18 | mU/l | fasting (for 12 hours) | 103811 | fasting (for 12 hours) | | | |
4 | plasma insulin level | GK/MolTac | male | 38.74 | mU/l | sodium chloride solution (for 23 days) then fasting (for 12 hours) | 103812 | sodium chloride solution (for 23 days) | fasting (for 12 hours) | | |
3 | plasma insulin level | GK/MolTac | male | 30.42 | mU/l | rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) | 103813 | rosiglitazone (5 mg/kg) (for 23 days) | fasting (for 12 hours) | | |
4 | plasma insulin level | GK/MolTac | male | 34.58 | mU/l | rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) | 103814 | rosiglitazone (10 mg/kg) (for 23 days) | fasting (for 12 hours) | | |
4 | plasma insulin level | GK/MolTac | male | 37.96 | mU/l | sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) | 103815 | sodium chloride solution (for 23 days) | control condition (for 20 days) | fasting (for 12 hours) | |
4 | plasma insulin level | GK/MolTac | male | 38.22 | mU/l | rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) | 103816 | rosiglitazone (5 mg/kg) (for 23 days) | control condition (for 20 days) | fasting (for 12 hours) | |
4 | plasma insulin level | GK/MolTac | male | 27.3 | mU/l | rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) | 103817 | rosiglitazone (10 mg/kg) (for 23 days) | control condition (for 20 days) | fasting (for 12 hours) | |
6 | plasma insulin level | Crl:WI(Han) | female | 221 | mU/l | sham surgical control condition (for 24 days) | 103761 | sham surgical control condition (for 24 days) | | | |
6 | plasma insulin level | Crl:WI(Han) | female | 213.2 | mU/l | bilateral ovariectomy (for 24 days) | 103762 | bilateral ovariectomy (for 24 days) | | | |
6 | plasma insulin level | GK | female | 26 | mU/l | sham surgical control condition (for 24 days) | 103763 | sham surgical control condition (for 24 days) | | | |
6 | plasma insulin level | GK | female | 23.4 | mU/l | bilateral ovariectomy (for 24 days) | 103764 | bilateral ovariectomy (for 24 days) | | | |
6 | plasma insulin level | SD-Lepem1Sage-/- | female | 971.88 | mU/l | fasting (for 4 hours) | 104457 | fasting (for 4 hours) | | | |
6 | plasma insulin level | SD-Lepem1Sage+/+ | male | 14.82 | mU/l | fasting (for 4 hours) | 104454 | fasting (for 4 hours) | | | |
6 | plasma insulin level | SD-Lepem1Sage-/- | male | 327.08 | mU/l | fasting (for 4 hours) | 104455 | fasting (for 4 hours) | | | |
6 | plasma insulin level | SD-Lepem1Sage+/+ | female | 18.2 | mU/l | fasting (for 4 hours) | 104456 | fasting (for 4 hours) | | | |
10 | plasma insulin level | GK | male | 11.96 | mU/l | fasting (for 16 hours) | 109082 | fasting (for 16 hours) | | | |
10 | plasma insulin level | GK | male | 11.44 | mU/l | fasting (for 16 hours) | 109083 | fasting (for 16 hours) | | | |
10 | plasma insulin level | GK | male | 11.7 | mU/l | fasting (for 16 hours) | 109085 | fasting (for 16 hours) | | | |
5 | plasma insulin level | Crlj:WI | male | 62.4 | mU/l | fasting (for 17 hours) | 108088 | fasting (for 17 hours) | | | |
44 | plasma insulin level | Slc:ZUC-Leprfa-/- | male | 384.8 | mU/l | fasting (for 17 hours) | 106938 | fasting (for 17 hours) | | | |
10 | plasma insulin level | GK/CskCrlj | male | 28.6 | mU/l | fasting (for 17 hours) | 106892 | fasting (for 17 hours) | | | |
8 | plasma insulin level | Crl:WI | male | 6.24 | mU/l | control condition | 105532 | control condition | | | |
8 | plasma insulin level | WI-Mc4rm1Hubr | male | 39 | mU/l | control condition | 105533 | control condition | | | |
9 | plasma insulin level | Slc:ZUC-Leprfa+ | male | 26 | mU/l | fasting (for 17 hours) | 108658 | fasting (for 17 hours) | | | |
6 | plasma insulin level | BN/Crl | male | 6.396 | mU/l | fasting (between 16 and 18 hours) | 68776 | fasting (between 16 and 18 hours) | | | |
6 | plasma insulin level | BN/Crl | female | 6.058 | mU/l | fasting (between 16 and 18 hours) | 68777 | fasting (between 16 and 18 hours) | | | |
6 | plasma insulin level | GK/Ox | male | 18.798 | mU/l | fasting (between 16 and 18 hours) | 68778 | fasting (between 16 and 18 hours) | | | |
6 | plasma insulin level | GK/Ox | female | 9.1 | mU/l | fasting (between 16 and 18 hours) | 68779 | fasting (between 16 and 18 hours) | | | |
15 | plasma insulin level | BN/Crl | male | 7.19425 | mU/l | control condition | 67327 | control condition | | | |
12 | plasma insulin level | BN.GK-(D8Rat29-D8Got130)/Ox | male | 4.02878 | mU/l | control condition | 67328 | control condition | | | |
15 | plasma insulin level | BN.GK-(D8Got302-D8Got130)/Ox | male | 3.45324 | mU/l | control condition | 67329 | control condition | | | |
20 | plasma insulin level | BN/Crl | male | 5.46763 | mU/l | control condition | 67330 | control condition | | | |
12 | plasma insulin level | BN.GK-(D8Rat29-D8Got130)/Ox | male | 6.762595 | mU/l | control condition | 67331 | control condition | | | |
11 | plasma insulin level | BN.GK-(D8Got302-D8Got130)/Ox | male | 3.309355 | mU/l | control condition | 67332 | control condition | | | |
12 | plasma insulin level | BN/Crl | female | 4.31655 | mU/l | control condition | 67333 | control condition | | | |
10 | plasma insulin level | BN.GK-(D8Rat29-D8Got130)/Ox | female | 6.04317 | mU/l | control condition | 67334 | control condition | | | |
18 | plasma insulin level | BN.GK-(D8Got302-D8Got130)/Ox | female | 2.733815 | mU/l | control condition | 67335 | control condition | | | |
10 | plasma insulin level | BN/Crl | female | 7.050365 | mU/l | control condition | 67336 | control condition | | | |
7 | plasma insulin level | BN.GK-(D8Rat29-D8Got130)/Ox | female | 4.31655 | mU/l | control condition | 67337 | control condition | | | |
10 | plasma insulin level | BN.GK-(D8Got302-D8Got130)/Ox | male | 5.323745 | mU/l | control condition | 67338 | control condition | | | |